Department of Veterans Affairs, Center for Healthcare Organization and Implementation Research, Edith Norse Rogers Memorial VA Hospital, VA BridgeQUERI, Bedford, MA.
Department of Veterans Affairs, Roudebush VA Medical Center, HSR&D Center for Health Information & Communication, VA PRIS-M QUERI.
Med Care. 2020 May;58(5):e31-e38. doi: 10.1097/MLR.0000000000001319.
The Department of Veterans Affairs (VA) cares for more patients with hepatitis C virus (HCV) than any other US health care system. We tracked the implementation strategies that VA sites used to implement highly effective new treatments for HCV with the aim of uncovering how combinations of implementation strategies influenced the uptake of the HCV treatment innovation. We applied Configurational Comparative Methods (CCMs) to uncover causal dependencies and identify difference-making strategy configurations, and to distinguish higher from lower HCV treating sites.
We surveyed providers to assess VA sites' use of 73 implementation strategies to promote HCV treatment in the fiscal year 2015. CCMs were used to identify strategy configurations that uniquely distinguished higher HCV from lower HCV treating sites.
From the 73 possible implementation strategies, CCMs identified 5 distinct strategy configurations, or "solution paths." These were comprised of 10 individual strategies that collectively explained 80% of the sites with higher HCV treatment starts with 100% consistency. Using any one of the following 5 solution paths was sufficient to produce higher treatment starts: (1) technical assistance; (2) engaging in a learning collaborative AND designating leaders; (3) site visits AND outreach to patients to promote uptake and adherence; (4) developing resource sharing agreements AND an implementation blueprint; OR (5) creating new clinical teams AND sharing quality improvement knowledge with other sites AND engaging patients. There was equifinality in that the presence of any one of the 5 solution paths was sufficient for higher treatment starts.
Five strategy configurations distinguished higher HCV from lower HCV treating sites with 100% consistency. CCMs represent a methodological advancement that can help inform high-yield implementation strategy selection and increase the efficiency and effectiveness of future implementation efforts.
美国退伍军人事务部(VA)为比任何其他美国医疗保健系统更多的丙型肝炎病毒(HCV)患者提供治疗。我们跟踪了 VA 站点实施新的高效 HCV 治疗方法所采用的实施策略,旨在揭示实施策略的组合如何影响 HCV 治疗创新的采用。我们应用了配置比较方法(CCM)来揭示因果关系并确定产生差异的策略配置,以及区分 HCV 治疗水平较高和较低的站点。
我们调查了医疗服务提供者,以评估 VA 站点在 2015 财年中使用 73 种实施策略来促进 HCV 治疗的情况。CCM 用于识别独特地区分 HCV 治疗水平较高和较低的站点的策略配置。
从 73 种可能的实施策略中,CCM 确定了 5 种独特的策略配置,或“解决方案路径”。这些配置由 10 种单独的策略组成,共同解释了 80%的 HCV 治疗水平较高的站点,一致性达到 100%。使用以下 5 种解决方案路径中的任何一种都足以提高治疗开始率:(1)技术援助;(2)参与学习合作并指定领导者;(3)现场访问和患者外展以促进采用和依从性;(4)制定资源共享协议和实施蓝图;或(5)创建新的临床团队,与其他站点共享质量改进知识并参与患者。存在均等性,即 5 种解决方案路径中的任何一种都足以提高治疗开始率。
5 种策略配置可以 100%一致地区分 HCV 治疗水平较高和较低的站点。CCM 代表了一种方法上的进步,可以帮助确定高收益的实施策略选择,并提高未来实施工作的效率和效果。